CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition
Authors
Keywords
Chemokine, Cytokine, Tumor cell migration, Tumor metastasis, Tumor microenvironment
Journal
Cell Communication and Signaling
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-10
DOI
10.1186/s12964-019-0434-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer
- (2017) Shumei Kato et al. INVESTIGATIONAL NEW DRUGS
- Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence
- (2016) Isabel Coutinho et al. ENDOCRINE-RELATED CANCER
- Stromal factors involved in human prostate cancer development, progression and castration resistance
- (2016) Noemi Eiro et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer
- (2016) W S Jang et al. PROSTATE CANCER AND PROSTATIC DISEASES
- CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment
- (2016) Tao Zhang et al. Nature Communications
- Comparative Efficiency and Impact on the Activity of Blood Neutrophils Isolated by Percoll, Ficoll and Spontaneous Sedimentation Methods
- (2015) Tainá Mosca et al. IMMUNOLOGICAL INVESTIGATIONS
- Differential Activation of Inflammatory Pathways in Testicular Macrophages Provides a Rationale for Their Subdued Inflammatory Capacity
- (2015) Sudhanshu Bhushan et al. JOURNAL OF IMMUNOLOGY
- Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer
- (2015) Guanxiong Ding et al. PROSTATE
- Neutrophils Increase Oral Squamous Cell Carcinoma Invasion through an Invadopodia-Dependent Pathway
- (2015) J. E. Glogauer et al. Cancer Immunology Research
- Neutrophils in Cancer: Two Sides of the Same Coin
- (2015) Eileen Uribe-Querol et al. Journal of Immunology Research
- Secretome Analysis of an Osteogenic Prostate Tumor Identifies Complex Signaling Networks Mediating Cross-talk of Cancer and Stromal Cells Within the Tumor Microenvironment
- (2014) Yu-Chen Lee et al. MOLECULAR & CELLULAR PROTEOMICS
- In vivo transcriptional governance of hair follicle stem cells by canonical Wnt regulators
- (2014) Wen-Hui Lien et al. NATURE CELL BIOLOGY
- Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer
- (2013) Makito Miyake et al. PATHOLOGY RESEARCH AND PRACTICE
- Clinical development of novel therapeutics for castration-resistant prostate cancer
- (2012) Matthew D. Galsky et al. CA-A CANCER JOURNAL FOR CLINICIANS
- EMT in carcinoma progression and dissemination: Facts, unanswered questions, and clinical considerations
- (2012) Jeremy Bastid CANCER AND METASTASIS REVIEWS
- CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation
- (2012) Po-Lin Kuo et al. CARCINOGENESIS
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- CXCL8, an Underestimated “Bad Guy” in Prostate Cancer
- (2012) Zoran Culig EUROPEAN UROLOGY
- Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer
- (2012) Jiang Yang et al. FASEB JOURNAL
- CXCL1 can be regulated by IL-6 and promotes granulocyte adhesion to brain capillaries during bacterial toxin exposure and encephalomyelitis
- (2012) Monica Roy et al. Journal of Neuroinflammation
- Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
- (2012) Yu Sun et al. NATURE MEDICINE
- EMT as the ultimate survival mechanism of cancer cells
- (2012) Neha Tiwari et al. SEMINARS IN CANCER BIOLOGY
- The tumor microenvironment in prostate cancer: elucidating molecular pathways for therapy development
- (2012) Paul G Corn Cancer Management and Research
- Lipocalin 2 in cancer: When good immunity goes bad
- (2011) Jeffrey J. Rodvold et al. CANCER LETTERS
- Macrophages induce neuroendocrine differentiation of prostate cancer cells via BMP6-IL6 Loop
- (2011) Geun Taek Lee et al. PROSTATE
- Neutrophils: key mediators of tumour angiogenesis
- (2010) Simon Tazzyman et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Kallikrein-related peptidase-4 initiates tumorâstroma interactions in prostate cancer through protease-activated receptor-1
- (2009) Wenbin Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Genomic Strategy for Targeting Therapy in Castration-Resistant Prostate Cancer
- (2009) Prateek Mendiratta et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
- (2009) Tim P. Green et al. Molecular Oncology
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Stromal myofibroblasts are drivers of invasive cancer growth
- (2008) Olivier De Wever et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started